<?xml version="1.0" encoding="UTF-8"?>
<fig id="f01" position="float">
 <label>Figure 1</label>
 <caption>
  <p>Illustrative scheme of ACE-2 expression in the lungs. Left panel: Normally expressed ACE-2 in the lung tissue interacts with SARS-CoV-2. Middle panel: Increased expression of ACE-2 in lung tissues of hypertensive patients under chronic treatment with AT1R blockers. Right panel: ADAM17 cleaves ACE-2, releasing its soluble form, sACE-2, whose levels are increased in the presence of TNF-Î±. Illustration was developed by the authors using 
   <ext-link ext-link-type="uri" xlink:href="www.biorender.com" xmlns:xlink="http://www.w3.org/1999/xlink">www.biorender.com</ext-link>.
  </p>
 </caption>
 <graphic xlink:href="cln-75-e1912-g001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
